Stocks Generating Improved Relative Strength: Travere
In a welcome move, Travere saw its Relative Strength Rating rise from 67 to 79 on Wednesday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This exclusive rating from Investor's Business Daily identifies price action with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the market's biggest winners often have an 80 or higher RS Rating in the early stages of their moves. See if Travere can continue to show renewed price strength and clear that threshold.
While the stock is not near a proper entry right now, see if it manages to form and break out from a proper chart pattern.
While earnings-per-share growth declined in the prior quarter from 0% to -77%, sales rose 13%, up from -1% in the prior report.
The company holds the No. 167 rank among its peers in the Medical-Biomed/Biotech industry group. Maravai Lifesciences and Biontech Se Ads are also among the group's highest-rated stocks.